Bioray Biotech CoROCO:7561 +4.43%82 Interest Coverage is 38.73 as of Dec. 2025, which is 34% below its 10-year median of 58.50. GuruFocus rates ROCO:7561 with a GF Score™ of 82/100 and a GF Value™ of NT$29.48 (Significantly Undervalued). Among 684 Drug Manufacturers companies, Bioray Biotech Co ranks better than 73.25% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Bioray Biotech Co's
Operating Income
for the
six
months ended in Dec. 2025 was NT$14.3 Mil. Bioray Biotech Co's Interest Expense for the
six
months ended in Dec. 2025 was NT$-0.4 Mil.
Bioray Biotech Co's interest coverage for the quarter that ended in Dec. 2025 was 38.73.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Bioray Biotech Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Bioray Biotech Co's Interest Coverage or its related term are showing as below:
ROCO:7561'
s Interest Coverage Range Over the Past 10 Years
Min: 0.08 Med: 58.5 Max: No Debt
Current: 58.5
ROCO:7561's Interest Coverage is ranked better than 73.25% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs ROCO:7561: 58.50
Bioray Biotech Co (ROCO:7561) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Bioray Biotech Co Interest Coverage Related Terms
Bioray Biotech Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Bioray Biotech Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:7561 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bioray Biotech Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioray Biotech Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bioray Biotech Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Bioray Biotech Co's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioray Biotech Co (ROCO:7561) has a Interest Coverage of 38.73 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bioray Biotech Co and its competitors. This is 34% below median its historical median of 58.50. Over the past decade, Bioray Biotech Co's Interest Coverage has ranged from 0.08 to 10,000.00. According to the industry distribution chart, Bioray Biotech Co ranks #183 out of 684 companies in the Drug Manufacturers industry, placing it in the top 26.8%.
Is Bioray Biotech Co's Interest Coverage too high?
Bioray Biotech Co's current Interest Coverage of 38.73 is 34% below median its 10-year median of 58.50. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 10,000.00. The Drug Manufacturers industry median Interest Coverage is 12.77. Bioray Biotech Co's value of 38.73 is 203.4% above this industry median. Based on the distribution chart, Bioray Biotech Co ranks #183 out of 684 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bioray Biotech Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioray Biotech Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Bioray Biotech Co ranks #183 out of 684 companies for Interest Coverage. This puts Bioray Biotech Co in the upper half of its industry. The industry median Interest Coverage is 12.77. Bioray Biotech Co's value of 38.73 is 203.4% above this benchmark. Historically, Bioray Biotech Co's own Interest Coverage has ranged from 0.08 to 10,000.00 over the past decade. While the company's 10-year median is 58.50 vs. the industry median of 12.77, Bioray Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioray Biotech Co's current Interest Coverage of 38.73 is 203.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bioray Biotech Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioray Biotech Co's current Interest Coverage is 38.73, which is 34% below median its own 10-year median of 58.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioray Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Bioray Biotech Co (ROCO:7561) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$29.48, compared to a current price of NT$18.85 — trading 36.1% below its estimated fair value. The current Interest Coverage is 38.73, which is 34% below median its 10-year median of 58.50 and 203.4% above the Drug Manufacturers industry median of 12.77. Bioray Biotech Co's overall GF Score™ is 82/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Bioray Biotech Co (ROCO:7561), the current Interest Coverage is 38.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioray Biotech Co (ROCO:7561) Overvalued in 2026?
Based on GuruFocus' analysis, Bioray Biotech Co stock appears to be undervalued.
The current stock price of NT$18.85 is trading 36.1% below its estimated GF Value™ of NT$29.48.
GuruFocus considers Bioray Biotech Co to be Significantly Undervalued.
Key valuation signals for ROCO:7561:
Interest Coverage: 38.73 (34% below median its 10-year median of 58.50)
GF Value™: NT$29.48 vs. price of NT$18.85 (36.1% below fair value)
Industry Position: 203.4% above the Drug Manufacturers median (#183 of 684)
No single metric tells the full story. See the ROCO:7561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations.
82GF Score
Get the complete analysis for ROCO:7561
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7561 has been successfully added to your 
